Procedures for Reimbursement Reviews

To ensure a smooth and efficient process, it is important that sponsors pay careful attention to CDA-AMC documentation. As documentation posted to the CDA-AMC website is subject to change, please access this content as it is needed instead of downloading and archiving it. It is important to read the following documents in conjunction with the Pharmaceutical Reviews Update, which communicates updates to procedures and general program developments. To receive new issues of the Pharmaceutical Reviews Update, please subscribe to the Weekly Summary email.

Procedures

The Procedures for Reimbursement Reviews details the process to be followed by all participants involved in a drug reimbursement review, and provides guidance to sponsors in the preparation of their applications. These procedures are effective for all oncology applications received on or after April 28, 2025, and non-oncology applications received on or after May 12, 2025. For applications received prior to those dates, please refer to the previous procedural document.

Fee Schedule

CDA-AMC has a fee structure that applies to its drug reimbursement review processes, please consult the Fee Schedule for Pharmaceutical Reviews for complete details

Templates

The following templates are to be used by sponsors throughout the reimbursement review process:

Templates for Presubmission Phase

Pharmaceutical submission SharePoint access request form 

Eligibility inquiry form

Advance notification form

Proposed place in therapy template

Evidence presentation meeting briefing paper template

Pipeline meeting briefing paper template

Note: The presubmission meeting templates below are only applicable for oncology applications received before April 28, 2025, and non-oncology applications received before May 12, 2025:

Pre-submission meeting request form

Pre-submission meeting briefing paper template 

Last Updated : September 28, 2023

Procedures for Reimbursement Reviews